MIND-WELL Intervention

Study summary

Lung cancer patients often go through more than one type of treatment, such as chemotherapy, radiation, and immunotherapy. These treatments can lead to several transition periods, which may increase stress and leave some needs unmet for patients and their family caregivers. The purpose of this study is to find out whether a program that includes mindfulness (stress reduction) and education is helpful, acceptable, and practical for lung cancer patients and their family caregivers. We also want to learn if this program helps them feel better prepared during these transitions.

Ask AI to explain this study

Start here

Key things to know

Main goalSupportive Care

This describes the study’s primary purpose.

What is being studiedMIND-WELL Intervention (MINDfulness-based Intervention for Navigation of Dyadic WELLness and Education During Transitions)

The study team can explain what participation involves.

Who it may be forLung Cancer (Diagnosis) · Caregiver

These are broad labels—not an eligibility decision.

Checked against the public recordLast updated Sep 24, 2026 · Source: ClinicalTrials.gov

Is enrollment open?Not Yet Recruiting

The study is not accepting participants yet.

What kind of study?Not applicable

Interventional

Where is it offered?1 U.S. location

Locations may change over time.

Who runs it?University of Arizona

Study sponsor

Study overview

What this study is about

Purpose: Supportive Care
Study type: Interventional
Phase: Not applicable
Sponsor: University of Arizona
Interventions being studied: Behavioral: MIND-WELL Intervention (MINDfulness-based Intervention for Navigation of Dyadic WELLness and Education During Transitions)

Explore related studies

How this study is categorized

These labels come from structured fields and exact terms in the public record.

Treatment approach

Immunotherapy→Chemotherapy→Supportive or behavioral care→

Public criteria

Who may be able to participate

The sponsor separates these requirements into two groups. You do not need to interpret them alone—use them to guide a conversation with the study team.

Requirements people may need to meetInclusion criteria

Non-healthy adults:
Lung cancer patients aged 18 years or older who are currently receiving or scheduled to initiate active treatment, including those diagnosed with small cell or non-small cell lung cancer (Stage I-IV)

Reasons someone may not be able to joinExclusion criteria

Lung cancer patients who are under 18 years of age or unable to read and speak English will be excluded. Individuals with known severe psychiatric illness (e.g., active psychosis or acute psychiatric instability) or severe physical illness that would prevent meaningful participation in the intervention activities, as determined during the eligibility screening process, will be excluded Healthy adults:
Inclusion Criteria: Family caregivers aged 18 years or older who are providing any type of support (physical, emotional, social, financial) to the lung cancer patients

Important: This is the sponsor’s public criteria, not a determination of eligibility. The study team must review your individual situation.

Study sites

U.S. locations

University of Arizona Cancer CenterTucson, Arizona

Source and freshness
Processed from ClinicalTrials.gov. Last public update: Sep 24, 2026. Always confirm current availability with the study team.

View original record ↗